Bayer invests € 100 million in sustainable healthcare products to advance the company’s sustainability commitments to 2030

BASEL, Switzerland – (COMMERCIAL THREAD) – Bayer today announced that the company invest 100 million euros to further enable innovation, sustainable production and consumption of our consumer health products, which include global brands such as Aspirin, Bepanthen, Claritin, and Elevit. This investment, which is equivalent to two percent of the division’s sales, will enable Bayer to promote the sustainable use of the company’s products and help create a world where people can live healthier lives.

“The climate crisis is impacting all families around the world, especially those in underserved communities, and is one of the greatest threats to global health of our time,” said Heiko Schipper, Board Member of Bayer AG and Chairman of Bayer’s Consumer Health. Division. “Through this investment and our commitment to expand access to everyday health to 100 million people in underserved communities by 2030, our goal is to help create a healthier world for all.”

Over the past 20 yearsI, climate change is causing a growing number of chronic diseases and other health problems, disproportionately affecting vulnerable populations, including children, the elderly, minorities and members of the most vulnerable communities. poor. With the company’s vision of “health for all, hunger for no one”, Bayer is committed to climate action, both for the good of the planet and the lives of its inhabitants.

Bayer has a three-pronged science action plan in line with the company’s science goals of being climate neutral by 2030 and net zero by 2050:

1. Prioritize sustainable brands, products and packaging

Bayer is committed to finding new solutions that inspire the sustainable creation and consumption of the company’s over-the-counter products and supplements. As such, the division has implemented a “recycle, reduce, be responsible and replace” approach and has set itself the following objectives: 100% of Bayer Consumer Health’s packaging will be recyclable or reusable by 2030I and all packaging will include user-friendly recycling information. Within the same timeframe, the division’s packaging will contain an average of 50% recycled content and 100% of the paper purchased will come from sustainable sources. Progress to date includes:

  • Shipping boxes will be 80% recycled content by the end of 2021.

  • Beginning of the conversion of paper packaging from global brands such as Aleve, Claritin, Iberogast and Redoxon, to use certified paper from responsibly managed forests.

  • Implemented a program to transition to digital marketing and reduce the division’s printed promotional material footprint.

  • 100% of new product development projects are assessed for their sustainability performance in the areas of health, environment and access

2. Urge collective action

The climate change emergency requires a partnership to have an impact. “No single entity can win the fight against climate change on its own,” added Schipper. “We must come together under a common vision to advance sustainable personal health care around the world. ”

The division recently contributed to the development and signing of the Global Self-Care Federation’s Environmental Sustainability Charter, which allows Bayer to work on multiple competitive lines to encourage industry-wide environmental advancements. focused on reducing carbon emissions and more sustainable packaging.

3. Turbocharge’s commitment to Net Zero

In line with Bayer’s global commitment to climate neutrality by 2030 (Scopes 1 and 2) and net zero across the entire value chain (Scopes 1, 2 and 3) by 2050, the Consumer Health division is taking specific measures to increase energy efficiency and go renewable. Progress to date includes:

  • Reduction of the carbon footprint of all production facilities through energy efficiency and renewable energy projects, contributing to a 30% reduction in carbon emissions between 2019 and 2020.

  • 65% of the energy consumed at three Consumer Health production sites (one in Germany, one in Guatemala and one in Spain) is produced from renewable sources.

About Bayer

Bayer is a global company with core competencies in the fields of life sciences, healthcare and nutrition. Its products and services are designed to help people and the planet prosper by supporting efforts to meet the major challenges presented by a growing and aging global population. Bayer is committed to promoting sustainable development and generating a positive impact with its activities. At the same time, the Group aims to increase its profitability and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality around the world. In fiscal year 2020, the Group employed around 100,000 people and generated sales of € 41.4 billion. R&D expenses before exceptional items amounted to 4.9 billion euros. For more information, visit


I Where permitted and permitted by quality and safety regulations.

Maria J. Book